Related Experiment Videos
Pemphigus vulgaris and vegetans
1Department of Dermatology, Strong Memorial Hospital, Rochester, New York.
Dermatologic Clinics
|July 1, 1993
Summary
Pemphigus vulgaris is an autoimmune blistering disease affecting skin and mucous membranes. Research aims to develop new therapies to avoid systemic glucocorticoid side effects.
Area of Science:
- Immunodermatology
- Autoimmune diseases
- Pathophysiology
Background:
- Pemphigus vulgaris is an autoimmune blistering disorder affecting skin and mucous membranes.
- It typically affects the elderly and has a strong immunogenetic link.
- Current treatments involve systemic glucocorticoids, leading to global immunosuppression.
Purpose of the Study:
- To explore the pathophysiology of blister formation in pemphigus vulgaris.
- To characterize the pemphigus antigen.
- To identify novel therapeutic strategies to mitigate treatment-related immunosuppression.
Main Methods:
- Immunologic studies
- Research into pemphigus antigen characteristics
- Investigation of novel therapeutic techniques
Main Results:
- Understanding of pemphigus vulgaris pathophysiology and antigen characteristics.
- Identification of potential pathways for new treatment development.
Conclusions:
- New therapies are needed to prevent the immunosuppression associated with current pemphigus vulgaris treatments.
- Further research into novel techniques may lead to safer and more effective treatments for this disorder.